Close

Athersys (ATHX) Announces RMAT Designation From FDA

October 5, 2017 7:10 AM EDT Send to a Friend
Athersys, Inc. (NASDAQ: ATHX) announced today that Robert W. Mays, Ph.D., Vice President, Regenerative Medicine and Head of Neuroscience Programs ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login